Advertisement

Topics

VCLS Appoints Dr. Gopalan Narayanan, Vice-President, Disruptive Biologics

03:00 EST 8 Mar 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Previously head of the MHRA’s Biologicals unit, Dr. Narayanan provides strategic advice to leading developers of complex biologics, in particular Advanced Therapy Medicinal Products (ATMP)s, which address areas of high unmet m...

Other Sources for this Article

Voisin Consulting Life Sciences
Zhengxi Danard, +33 1 41 31 83 00
vcparis@voisinconsulting.com

NEXT ARTICLE

More From BioPortfolio on "VCLS Appoints Dr. Gopalan Narayanan, Vice-President, Disruptive Biologics"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotherapeutics
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...